Roble Belko & Company Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$7.77M |
| 2 |
iShares Short Maturity Bond ETF
NEAR
|
+$4.72M |
| 3 |
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
|
+$1.87M |
| 4 |
Vanguard Ultra-Short Bond ETF
VUSB
|
+$1.33M |
| 5 |
BlackRock Short Maturity Municipal Bond ETF
MEAR
|
+$671K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 2.38% |
| 2 | Consumer Discretionary | 2.09% |
| 3 | Technology | 1.04% |
| 4 | Healthcare | 0.58% |
| 5 | Financials | 0.48% |
Similar funds
Roble Belko & Company's Q4 2022 Portfolio in Review
As of Q4 2022, Roble Belko & Company held 360 positions worth $470M, up 14% from $412M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Roble Belko & Company deployed $28.9M of net new capital in Q4 2022, opening 18 new positions and adding to 55 existing holdings. Its largest new stake was Vanguard Total Bond Market: 152,338 shares worth $10.9M.
By sector, the portfolio is most concentrated in Real Estate at 2.4% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was iShares Ultra Short Duration Bond Active ETF, an estimated $7.77M trimmed.
- Roble Belko & Company's largest Q4 2022 buy was Vanguard Total Bond Market: 152,338 shares worth $10.9M.
- Roble Belko & Company added most to Vanguard Morningstar Total Stock Market ETF in Q4 2022, an estimated $6.86M increase.
- Roble Belko & Company's biggest Q4 2022 reduction was iShares Ultra Short Duration Bond Active ETF, cutting an estimated $7.77M.
- Roble Belko & Company fully exited BlackRock Short Maturity Municipal Bond ETF in Q4 2022, selling an estimated $671K.
- Roble Belko & Company's ten largest holdings make up 53% of its $470M portfolio in Q4 2022.
- Roble Belko & Company opened 18 new positions and closed 16 in Q4 2022.
- Roble Belko & Company's portfolio value rose 14% quarter-over-quarter to $470M.
Based on Roble Belko & Company's 13F filing for Q4 2022, filed 8 Feb 2023.